Owc Pharmaceutical Research
(OTC) OWCP
Owc Pharmaceutical Research Financials at a Glance
Market Cap
$500.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$0.00
Net Income (TTM)
$1.34M
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
-84.52 (Low)
Dividend
$0.00
Beta (Volatility)
-84.52 (Low)
Price
$0.00
Volume
215
Open
$0.00
Price
$0.00
Volume
215
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.28
Estimated Earnings Date
N/A
Dividend
$0.00
Beta (Volatility)
-84.52 (Low)
Price
$0.00
Volume
215
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.28
Estimated Earnings Date
N/A
OWCP News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Owc Pharmaceutical Research
OWCP Financials
Key Financial Metrics (TTM)
Gross Margin
0.00%
Operating Margin
0.00%
Net Income Margin
0.00%
Return on Equity
237.20%
Return on Capital
N/A
Return on Assets
-288.71%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$500.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
497.50M
Volume
215
Avg. Volume
6.08K
Financials (TTM)
Gross Profit
$0.00
Operating Income
-$12.28M
EBITDA
-$7.26M
Operating Cash Flow
-$2.74M
Capital Expenditure
-$7.04K
Free Cash Flow
-$2.75M
Cash & ST Invst.
$1.47M
Total Debt
$47.00K
Owc Pharmaceutical Research Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonCurrently no data to display.
Quarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$500.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$55.56
N/A
Employees
9
N/A
Net Income
-$287.00K
+71.0%
EBITDA
-$685.00K
-2.7%
Quarterly Fundamentals
Total Cash
$1.47M
-65.3%
Total Debt
$47.00K
N/A
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$21.00K
N/A
Short Term Debt
$52.00K
N/A
Return on Assets
-2.89%
N/A
Return on Invested Capital
-1.38%
N/A
Free Cash Flow
-$372.00K
+13.4%
Operating Cash Flow
-$372.00K
+12.9%